Works matching IS 02724391 AND DT 2003 AND VI 58 AND IP 1

Results: 22

Transmural dispersion of action potential duration and heterogeneous changes in L-type calcium current in rabbit heart three months after myocardial infarction.

Published in:

Drug Development Research, 2003, v. 58, n. 1, p. 122, doi. 10.1002/ddr.10140

By:

Ma, Jie;
Li, Yang;
Zhang, Cun-Tai;
Xiao, Jian-Ming;
Lu, Zai-Ying

Publication type:

Article

Serotonin receptor as a potential therapeutic target for pulmonary vascular remodeling.

Published in:

Drug Development Research, 2003, v. 58, n. 1, p. 69, doi. 10.1002/ddr.10133

By:

Wang, Huailiang

Publication type:

Article

Mechanism of the delayed onset of action after intravenous amiodarone for treatment of ventricular arrhythmias.

Published in:

Drug Development Research, 2003, v. 58, n. 1, p. 145, doi. 10.1002/ddr.10144

By:

Shi, Guang-fei;
Xu, Wei;
Huang, Shen-shen;
Cao, Qiao-lan

Publication type:

Article

Nitric oxide release, EDHF, and the role of potassium channels in coronary circulation.

Published in:

Drug Development Research, 2003, v. 58, n. 1, p. 23, doi. 10.1002/ddr.10126

By:

He, Guo-Wei

Publication type:

Article

Bioassay of endothelium-derived hyperpolarizing factor with abolishment of nitric oxide and the role of gap junctions in the porcine coronary circulation.

Published in:

Drug Development Research, 2003, v. 58, n. 1, p. 99, doi. 10.1002/ddr.10137

By:

Yang, Qin;
Ge, Zhi-Dong;
Yang, Cheng-Qin;
Huang, Yu;
He, Guo-Wei

Publication type:

Article

CPU 86017 suppresses tachyarrhythmias induced by ouabain and myocardial infarction: Concentrations in plasma and different areas of the heart in dogs.

Published in:

Drug Development Research, 2003, v. 58, n. 1, p. 131, doi. 10.1002/ddr.10142

By:

Cui, Yu-Jin;
Yang, Ping;
Dai, De-Zai;
Gao, Ling;
Xiao, Da-Wei;
Wang, You-Qun

Publication type:

Article

Pharmacological characteristics of the novel antihypertensive drug, iptakalim hydrochloride, and its molecular mechanisms.

Published in:

Drug Development Research, 2003, v. 58, n. 1, p. 65, doi. 10.1002/ddr.10132

By:

Wang, Hai

Publication type:

Article

1,4-dihydropyridine calcium channel ligands: Selectivity of action. The roles of pharmacokinetics, state-dependent interactions, channel isoforms, and other factors.

Published in:

Drug Development Research, 2003, v. 58, n. 1, p. 5, doi. 10.1002/ddr.10124

By:

Triggle, David J.

Publication type:

Article

Effects of endothelin-1 mRNA antisense oligodeoxynucleotides on ischemic arrhythmias in isolated rat hearts.

Published in:

Drug Development Research, 2003, v. 58, n. 1, p. 138, doi. 10.1002/ddr.10143

By:

Yuan, Wen-Jun;
Qiu, Jing-Wei;
Lin, Li;
Pan, Xiu-Jie;
Ren, An-Jing;
Chen, Hong;
Tang, Chao-Shu

Publication type:

Article

Characteristic of Cl− current induced by ATP in bovine aortic endothelial cells.

Published in:

Drug Development Research, 2003, v. 58, n. 1, p. 53, doi. 10.1002/ddr.10129

By:

Wei, Wen-Li;
He, Hua;
Guan, Yong-Yuan

Publication type:

Article

Arterial baroreflex function and left ventricular hypertrophy.

Published in:

Drug Development Research, 2003, v. 58, n. 1, p. 61, doi. 10.1002/ddr.10131

By:

Miao, Chao-Yu;
Su, Ding-Feng

Publication type:

Article

Role of sarcolemmal and mitochondrial KATP channels and EDHF-mediated relaxation in coronary microarteries.

Published in:

Drug Development Research, 2003, v. 58, n. 1, p. 90, doi. 10.1002/ddr.10136

By:

Yang, Qin;
Zou, Wei;
Yim, Anthony P.C.;
Arifi, Ahmed A.;
He, Guo-Wei

Publication type:

Article

Third pathway: Endothelium-dependent hyperpolarization.

Published in:

Drug Development Research, 2003, v. 58, n. 1, p. 18, doi. 10.1002/ddr.10125

By:

Félétou, Michel;
Vanhoutte, Paul M.

Publication type:

Article

Contribution of EDHF and the role of potassium channels in the regulation of vascular tone.

Published in:

Drug Development Research, 2003, v. 58, n. 1, p. 81, doi. 10.1002/ddr.10135

By:

Ding, Hong;
Triggle, Chris R.

Publication type:

Article

International Symposium on Cardiovascular Remodeling, Ion Channelopathies, Arrhythmias, and Drug Treatment.

Published in:

Drug Development Research, 2003, v. 58, n. 1, p. 1, doi. 10.1002/ddr.10146

By:

Dai, De Zai;
Triggle, David J.

Publication type:

Article

Two patterns of ion channelopathies relating to arrhythmias and direct and indirect blockade of ion channels by antiarrhythmic agents.

Published in:

Drug Development Research, 2003, v. 58, n. 1, p. 42, doi. 10.1002/ddr.10128

By:

Dai, De-Zai;
Zhang, Guang-Qin;
Yang, Ping;
Ma, Yu-Ping

Publication type:

Article

L-thyroxine-induced vasodilation impairment and increased vascular response to norepinephrine are mediated by dysfunctional NO release.

Published in:

Drug Development Research, 2003, v. 58, n. 1, p. 116, doi. 10.1002/ddr.10139

By:

Yang, Ping;
Dai, De-Zai

Publication type:

Article

Effects of taurine and Astragalus membranaceus on ion currents and their expression in cardiomyocytes after CVB3 infection.

Published in:

Drug Development Research, 2003, v. 58, n. 1, p. 57, doi. 10.1002/ddr.10130

By:

Su, Yan-Gang;
Yang, Ying-Zhen;
Bao, Wei-Sheng;
Liu, Gong-Xin;
Ge, Jun Bo;
Chen, Haozhu

Publication type:

Article

L-thyroxine affects involvement of H1, 5-HT2, prostaglandin receptors and the endothelial NO system in allergic vascular response in guinea pigs.

Published in:

Drug Development Research, 2003, v. 58, n. 1, p. 125, doi. 10.1002/ddr.10141

By:

Hu, Hui-Juan;
Dai, De-Zai

Publication type:

Article

Effects of endothelin-1 antagonist BQ610 on hypoxia-induced injury and [Ca2+]i changes in cultured neonatal rat cardiomyocytes.

Published in:

Drug Development Research, 2003, v. 58, n. 1, p. 74, doi. 10.1002/ddr.10134

By:

Lin, Li;
Yuan, Wen-Jun

Publication type:

Article

Endothelial cell dysfunction in type I and II diabetes: The cellular basis for dysfunction.

Published in:

Drug Development Research, 2003, v. 58, n. 1, p. 28, doi. 10.1002/ddr.10127

By:

Pannirselvam, Malarvannan;
Anderson, Todd J.;
Triggle, Chris R.

Publication type:

Article

Reduced sodium currents in isolated mammalian myocytes treated with chronic L-thyroxine.

Published in:

Drug Development Research, 2003, v. 58, n. 1, p. 111, doi. 10.1002/ddr.10138

By:

Ma, Yu-Ping;
Hu, Hui-Juan;
Hao, Xue-Mei;
Zhou, Pei-Ai;
Wu, Cai-Hong;
Dai, De-Zai

Publication type:

Article

Works matching IS 02724391 AND DT 2003 AND VI 58 AND IP 1

Transmural dispersion of action potential duration and heterogeneous changes in L-type calcium current in rabbit heart three months after myocardial infarction.

Serotonin receptor as a potential therapeutic target for pulmonary vascular remodeling.

Mechanism of the delayed onset of action after intravenous amiodarone for treatment of ventricular arrhythmias.

Nitric oxide release, EDHF, and the role of potassium channels in coronary circulation.

Bioassay of endothelium-derived hyperpolarizing factor with abolishment of nitric oxide and the role of gap junctions in the porcine coronary circulation.

CPU 86017 suppresses tachyarrhythmias induced by ouabain and myocardial infarction: Concentrations in plasma and different areas of the heart in dogs.

Pharmacological characteristics of the novel antihypertensive drug, iptakalim hydrochloride, and its molecular mechanisms.

1,4-dihydropyridine calcium channel ligands: Selectivity of action. The roles of pharmacokinetics, state-dependent interactions, channel isoforms, and other factors.

Effects of endothelin-1 mRNA antisense oligodeoxynucleotides on ischemic arrhythmias in isolated rat hearts.

Characteristic of Cl<sup>−</sup> current induced by ATP in bovine aortic endothelial cells.

Arterial baroreflex function and left ventricular hypertrophy.

Role of sarcolemmal and mitochondrial K<sub>ATP</sub> channels and EDHF-mediated relaxation in coronary microarteries.

Third pathway: Endothelium-dependent hyperpolarization.

Contribution of EDHF and the role of potassium channels in the regulation of vascular tone.

International Symposium on Cardiovascular Remodeling, Ion Channelopathies, Arrhythmias, and Drug Treatment.

Two patterns of ion channelopathies relating to arrhythmias and direct and indirect blockade of ion channels by antiarrhythmic agents.

L-thyroxine-induced vasodilation impairment and increased vascular response to norepinephrine are mediated by dysfunctional NO release.

Effects of taurine and Astragalus membranaceus on ion currents and their expression in cardiomyocytes after CVB3 infection.

L-thyroxine affects involvement of H<sub>1</sub>, 5-HT<sub>2</sub>, prostaglandin receptors and the endothelial NO system in allergic vascular response in guinea pigs.

Effects of endothelin-1 antagonist BQ610 on hypoxia-induced injury and [Ca<sup>2+</sup>]<sub>i</sub> changes in cultured neonatal rat cardiomyocytes.

Endothelial cell dysfunction in type I and II diabetes: The cellular basis for dysfunction.

Reduced sodium currents in isolated mammalian myocytes treated with chronic L-thyroxine.